Abstract
The effect of an intravenous dose of 0.5 mg of scopolamine on the functional brain activity of normal subjects performing auditory discrimination (CPT) was determined in two independent positron emission tomography studies with [18F] 2-fluoro-deoxyglucose. In the first preliminary study, the most significant effect found was a reduction in the functional activity of the thalamus. In the second “hypothesis-testing” study, an equally prominent effect on thalamic functional activity was seen. Because the second study was performed on a high-resolution scanner with improved methodology, we re-examined scopolamine's effects on those brain regions established as determinants of CPT. Of the regions affected, the reduction in cingulate and the increase in basal ganglia metabolic rates were the most notable. We concluded that scopolamine's effects on the functions of thalamic, cingulate and basal ganglia are the likely causes of scopolamine's well-described attention-altering properties. Alterations in these same brain structures could be responsible for scopolamine's effects on other cognitive functions, e.g., memory. Alternatively, scopolamine's effects on other brain structures such as the hippocampus and frontal cortex could underlie scopolamine's effects on these other cognitive functions. Studies of scopolamine's regional metabolic effects in subjects performing these other cognitive tasks at more than a single dose and at more than one post-drug time are needed to discriminate between these two possibilities.
Similar content being viewed by others
References
Aigner TG, Walker DL, Mishkin M (1991) Comparison of the effects of scopolamine administered before and after acquisition in a test of visual recognition memory in monkeys. Behav Neural Biol 55:61–67
Bartus RT, Dean R, Beer B, Lippa AS (1982) The cholinergic hypothesis of geriatric memory dysfunction. Science 217:401–417
Battig W, Montague N (1969) Category norms for verbal items in 56 categories. J Exp Psychol Monog 80:1–43
Biegon A (1991) Acetylcholine, serotonin and adrenoceptors. In: Mendelsohn FAO, Paxinos G (eds) Receptors in the human nervous system. Academic Press, San Diego, pp 49–69
Branconnier RJ, Devitt DR, Cole JO, Spera KF (1982) Amitriptyline selectively disrupts verbal recall from secondary memory of the normal aged. Neurobiol Aging 3:55–59
Broks P, Preston GC, Traub M, Poppleton P, Ward C, Stahl SM (1988) Modelling dementia: effects of scopolamine on memory and attention. Neuropsychologia 26:685–700
Brooks R (1982) Alternative formula for glucose utilization using labeled deoxyglucose. J Nucl Med 23:538–539
Carlton PL (1963) Cholinergic mechanisms in the control of behavior by the brain. Psychol Rev 70:19–39
Clark C, Carson R, Kessler R, Margolin R, Buchsbaum M, DeLisi L, King C, Cohen R (1985) Alternative statistical models for the examination of clinical positron emission tomography/fluorodeoxyglucose data. J Cereb Blood Flow Metab 5:142–150
Cohen RM, Semple WE, Gross M, Holcomb HH, Dowling MS, Nordahl TE (1988) Functional localization of sustained attention: comparison to sensory stimulation in the absence of instruction. Neuropsychiatry Neuropsychol Behav Neurol 1:3–20
Cohen RM, Semple WE, Gross M, King AC, Nordahl TE (1992) The metabolic brain pattern of sustained auditory discrimination. Exp Brain Res 92:165–172
Crick F (1984) Function of the thalamic reticular complex: the searchlight hypothesis. Proc Natl Acad Sci USA 81:4586–4590
Dam M, London ED (1984) Glucose utilization in the Papez Circuit: effects of oxotremorine and scopolamine. Brain Res 295:137–144
Damasio AR, Damasio H, Chang Chui H (1980) Neglect following damage to frontal lobe or basal ganglia. Neuropsychologia 18:123–132
Davies P, Maloney AJ (1976) Selective loss of central cholinergic neurons in Alzheimer's disease. Lancet II:1403–1405
Deutsch JA (1971) The cholinergic synapse and the site of memory. Science 174:783–794
Drachman DA, Leavitt J (1974) Human memory and the cholinergic system. Arch Neurol 30:113–121
Drachman DA, Sahakian BJ (1979) Effects of cholinergic agents on human learning and memory. In: Barbeau A, Growdon JH, Wurtman RJ (eds) Nutrition and the brain, vol 5. Raven Press, New York, pp 355–366
Forstl H, Sahakian B (1993) Thalamic radiodensity and cognitive performance in mild and moderate dementia of the Alzheimer type. J Psychiatr Neurosci 18:33–37
Folstein M, Folstein S, McHugh PR (1975) Mini-Mental State: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12:189–198
Frey KA, Koeppe RA, Mulholland GK, Jewett D, Hichwa R, Ehrenkaufer RLE, Carey JE, Wieland DM, Kuhl DE, Agranoff BW (1992) In vivo muscarinic cholinergic receptor imaging in human brain with [11C] scopolamine and positron emission tomography. J Cereb Blood Flow Metab 12:147–154
Friedman HR, Goldman-Rakic PS (1988) Activation of the hippocampus and dentate gyrus by working-memory: a 2-deoxyglucose study of behaving rhesus monkey. J Neurosci 8:4693–4704
Frith CD, Friston K, Liddle PF, Frackowiak RSJ (1991) Willed action and the prefrontal cortex in man: a study with PET. Proc R Soc Lond [Biol] 244:241–246
Goldman-Rakic PS (1987) Circuitry of primate prefrontal cortex and regulation of behavior by representational memory. Handbook of Physiology section I, vol V. Oxford University Press, New York, pp 373–418
Guy W (1976) ECDEU: assessment manual for psychopharmacology. US Dept. of Health, Education, and Welfare, Washington DC
Haaren F van, Hest A van (1989) The effects of scopolamine and methylscopolamine on visual and auditory discriminations in male and female Wistar rats. Pharmacol Biochem Behav 32:707–710
Honer WG, Prohovnik I, Smith G, Lucas LR (1988) Scopolamine reduces frontal cortex perfusion. J Cereb Blood Flow Metab 8:635–641
Huang SC, Phelps ME, Hoffman EJ, Sideris K, Selin CJ, Kuhl DE (1980) Noninvasive determination of local cerebral metabolic rate of glucose in man. Am J Physiol 238:E69-E82
Izquierdo I (1989) Mechanism of action of scopolamine as an amnestic. Trends Pharmacol Sci 10:175–177
Kesner RP (1989) Parallel between animals and humans in terms of the neural foundations of memory: implications for Alzheimer's disease. In: Altman HJ, Altman BN (eds) Alzheimer's and Parkinson's diseases. Plenum Press, New York, pp 209–220
Laberge D, Buchsbaum MS (1990) Positron emission tomographic measurements of pulvinar activity during an attention task. J Neurosci 10:613–619
Matsui T, Hirano A (1978) An atlas of the human brain for computerized tomography. Igaku-Shoin, Tokyo
McGeer PL, Eccles JC, McGeer EG (1986) Cholinergic neurons. In: Molecular neurobiology of the mammalian brain, 2nd edn. Plenum Press, New York, pp 235–263
McGeer PL, McGeer EG, Mizukawa K, Tago H, Peng JH (1987) Distribution of cholinergic neurons in human brain. In: Dun NJ, Perlman RL (eds) Neurobiology of acetylcholine. Plenum Press, New York, pp 3–16
Mesulam M-M (1981) A cortical network for directed attention and unilateral neglect. Ann Neurol 10:309–325
Metter EJ, Riege WH, Kuhl DE, Phelps ME (1984) Cerebral metabolic relationships for selected brain regions in healthy adults. J Cereb Blood Flow Metab 4:1–7
Mishkin M, Malamut B, Bachevelair J (1984) Memories and habits: two neural systems. In: Lynch G, McGaugh JL, Weinberger NM (eds) Neurobiology of learning and memory. Guilford Press, New York, pp 61–77
Molchan SE, Martinez RA, Hill JL, Weingartner HJ, Thompson K, Vitiello B, Sunderland T (1992) Increased cognitive sensitivity to scopolamine with age and a perspective on the scopolamine model. Brain Res Rev 17:215–226
Muramoto O, Sugishita M, Ando K (1984) Cholinergic system and constructional praxis: a further study of physostigmine in Alzheimer's disease. J Neurol Neurosurg Psychiatry 47:485–491
Nissen MJ, Knopman DS, Schacter DL (1987) Neurochemical dissociation of memory systems. Neurology 789:794
Okaichi H, Oshima Y, Jarrard LE (1989) Scopolamine impairs both working and reference memory in rats: a replication and extension. Pharmacol Biochem Behav 34:599–602
Parrott AC (1986) The effects of transdermal scopolamine and four dose levels of oral scopolamine (0. 15, 0. 3, 0. 6 and 1. 2 mg) upon psychological performance. Psychopharmacology (Berl) 89:347–354
Pardo JV, Fox PT, Raichle ME (1991) Localization of a human system for sustained attention by positron emission tomography. Nature 349:61–64
Perry EK, Tomlinson BE, Blessed G, Bergman K, Bigson PH, Perry RH (1978) Correlation of cholinergic abnormalities with senile plaques and mental test scores in senile dementia. BMJ II:1457–1459
Posner MI, Petersen SE (1990) The attention system of the human brain. Annu Rev Neurosci 13:25–42
Ray PG, Meador KJ, Loring DW, Murro AM, Buccafusco JJ, Yang X-H, Zamrini EY, Thompson WO, Thompson EE (1991) Effects of scopolamine on visual evoked potentials in aging and dementia. Electroencephalogr Clin Neurophysiol 80:347–351
Rolls ET (1990) Experimental psychology: functions of different regions of the basal ganglia. In: Stern GM (eds) Parkinson's disease. Johns Hopkins University Press, Baltimore, pp 151–184
Rusted J, Eaton-Williams PE (1991) Distinguishing between attentional amnesic effects in information processing: the separate and combined effects of scopolamine and nicotine on verbal free recall. Psychopharmacology (Berl) 104:363–366
Safer DJ, Allen RP (1971) The central effects of scopolamine in man. Biol Psychiatry 3:347–355
Sahakian BJ (1988) Cholinergic drugs and human cognitive performance. In: Iversen LL, Iversen SD, Snyder SH (eds) Handbook of psychopharmacology, vol 20. Psychopharmacology of the aging nervous system. Plenum Press, New York, pp 393–424
Salvatierra A, Berry SD (1989) Scopolamine disruption of septohippocampal activity and classical conditioning. Behav Neurosci 103:715–721
Sarter M, Bodwitz G, Steckler T (1989) 2-[3H]deoxyglucose uptake patterns in rats exploring a six-arm radial tunnel maze: differences between experienced and nonexperienced rats. Behav Neurosci 103:1217–1225
Sato H, Hata Y, Masui H, Tsumoto T (1987) A functional role of cholinergic innervation to neurons in the cat visual cortex. J Neurophysiol 58:765–780
Semple WE, Johnson JL, Cohen R (1993) Reliability in positron emission tomography. In: London ED (eds) Imaging drug action in the brain. CRC Press, Boca Raton, pp 297–316
Sif J, Messier C, Meunier M, Bontempi B, Calas A, Destrade C (1991) Time-dependent sequential increases in [14C]2-deoxyglucose uptake in subcortical and cortical structures during memory consolidation of an operant training in mice. Behav Neural Biol 56:43–61
Smith AT, Early F, Jones GH (1990) Comparison of the effects of Alzheimer's disease, normal aging and scopolamine on human transient visual evoked potentials. Psychopharmacology (Berl) 102:535–543
Sokoloff L, Reivich M, Kennedy C, DesRosiers MH, Patlak CS, Pettigrew KD, Sakurada O, Shinohara M (1977) The [14C]deoxyglucose method for the determination of local cerebral glucose utilization: theory, procedure, and normal values in the conscious and anesthetized albino rat. J Neurochem 28:897–916
Squire L (1987) Memory and brain. Oxford University Press, New York
Steriade M, Jones EG, Llinas RR (1990) Thalamic oscillations and signaling. Wiley, New York
Sunderland T, Tariot PN, Weingartner H, Murphy DL, Newhouse PA, Mueller EA, Cohen RM (1986) Pharmacologic modelling of Alzheimer's disease. Prog Neuropsychopharmacol Biol Psychiatry 10:599–610
Warburton DM (1987) Drugs and the processing of information. In: Stahl SM, Iversen SD, Goodman EC (eds) Cognitive neurochemistry. Oxford University Press, Oxford, pp 111–134
Valenstein E, Heilman KM (1981) Unilateral hypokinesia and motor extinction. Neurology 31:445–448
Weinberger J, Greenberg JH, Waldman MTG, Sylvestro A, Reivich M (1979) The effect of scopolamine on local glucose metabolism in rat brain. Brain Res 177:337–345
Wesnes K, Warburton DM (1984) Effects of scopolamine and nicotine on human rapid information processing performance. Psychopharmacology (Berl) 82:147–150
Whitehouse PJ, Price DL, Struble RG, Clark AW, Coyle JT, De-Long MR (1982) Alzheimer's disease and senile dementia: loss of neurons in the basal forebrain. Science 215:1237–1239
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Cohen, R.M., Gross, M., Semple, W.E. et al. The metabolic brain pattern of young subjects given scopolamine. Exp Brain Res 100, 133–143 (1994). https://doi.org/10.1007/BF00227285
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00227285